APA (7th ed.) Citation

Deanfield, J., Verma, S., Scirica, B. M., Kahn, S. E., Emerson, S. S., Ryan, D., . . . Barone Rochette, G. (2024). Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: A prespecified analysis of the SELECT trial: a prespecified analysis of the SELECT trial. The Lancet, 404, 773-786. https://doi.org/10.1016/s0140-6736(24)01498-3

Chicago Style (17th ed.) Citation

Deanfield, John, et al. "Semaglutide and Cardiovascular Outcomes in Patients with Obesity and Prevalent Heart Failure: A Prespecified Analysis of the SELECT Trial: A Prespecified Analysis of the SELECT Trial." The Lancet 404 (2024): 773-786. https://doi.org/10.1016/s0140-6736(24)01498-3.

MLA (9th ed.) Citation

Deanfield, John, et al. "Semaglutide and Cardiovascular Outcomes in Patients with Obesity and Prevalent Heart Failure: A Prespecified Analysis of the SELECT Trial: A Prespecified Analysis of the SELECT Trial." The Lancet, vol. 404, 2024, pp. 773-786, https://doi.org/10.1016/s0140-6736(24)01498-3.